"Budesonide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.
| Descriptor ID |
D019819
|
| MeSH Number(s) |
D04.210.500.745.745.654.105
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Budesonide".
Below are MeSH descriptors whose meaning is more specific than "Budesonide".
This graph shows the total number of publications written about "Budesonide" by people in this website by year, and whether "Budesonide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 9 | 3 | 12 |
| 2018 | 7 | 2 | 9 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 2 | 3 |
| 2021 | 6 | 2 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Budesonide" by people in Profiles.
-
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021 09 04; 398(10303):843-855.
-
Inhaled Budesonide Reduces the Risk of Emergency Department Evaluation or Hospitalization in Early COVID-19. Am Fam Physician. 2021 08 01; 104(2):207-208.
-
Praxis (Bern 1994). 2021 08; 110(10):595-596.
-
Antiviral Effect of Budesonide against SARS-CoV-2. Viruses. 2021 07 20; 13(7).
-
Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19? CJEM. 2021 09; 23(5):611-612.
-
Recommendations for use of topical inhalant budesonide in COVID-19 : A Position Paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). HNO. 2021 08; 69(Suppl 2):35-38.
-
[Inhaled budesonide in the treatment of COVID-19]. Internist (Berl). 2021 Aug; 62(8):887-889.
-
[Recommendations for use of topical inhalant budesonide in COVID-19 : A position paper of the German Society for Applied Allergology (AeDA) and the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO). German version]. HNO. 2021 Aug; 69(8):611-614.
-
2021 American Thoracic Society International Conference. Lancet Respir Med. 2021 07; 9(7):e65-e66.
-
[Treatment of COVID-19 with Inhaled Glucocorticoids - Statement of the German Respiratory Society (DGP), the Austrian Society of Pneumology (ÖGP) and the German Society of Allergology and Clinical Immunology (DGAKI)]. Pneumologie. 2021 06; 75(6):418-420.